MBP-1 suppresses growth and metastasis of gastric cancer cells through COX-2

Molecular Biology of the Cell

Volumn 20, Issue 24, 2009, Pages 5127-5137

  Hsu, Kai Wen ^a,b   Hsieh, Rong Hong ^b   Wu, Chew Wun ^a,c   Chi, Chin Wen ^a,c   Lee, Yan Hwa Wu ^a   Kuo, Min Liang ^d   Wu, Kou Juey ^a   Yeh, Tien Shun ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR MBP1; UNCLASSIFIED DRUG;

ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG METASTASIS; MESENCHYME; PRIORITY JOURNAL; PROMOTER REGION; STOMACH ADENOCARCINOMA; TUMOR XENOGRAFT; WESTERN BLOTTING;

AMINO ACIDS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLOOXYGENASE 2; DISEASE PROGRESSION; DNA-BINDING PROTEINS; DOWN-REGULATION; EPITHELIUM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MESODERM; NEOPLASM METASTASIS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; STOMACH NEOPLASMS; STRUCTURE-ACTIVITY RELATIONSHIP;

MUS;

EID: 73849102191     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E09-05-0386     Document Type: Article

References (49)

1. Chang, Y. S., Wu, W., Walsh, G., Hong, W. K., and Mao, L. (2003). Enolase-α is frequently down-regulated in non-small cell lung cancer and predicts aggressive biological behavior. Clin. Cancer Res. 9, 3641-3644.
2. Chaudhary, D., and Miller, D. M. (1995). The c-myc promoter binding protein (MBP-1) and TBP bind simultaneously in the minor groove of the c-myc P2 promoter. Biochemistry 34, 3438-3445.
3. Chen, J. H., Wu, C. W., Kao, H. L., Chang, H. M., Li, A.F.Y., Liu, T. Y., and Chi, C. W. (2006). Effects of COX-2 inhibitor on growth of human gastric cancer cells and its relation to hepatocyte growth factor. Cancer Lett. 239, 263-270.
4. Demir, A. Y., Groothuis, P. G., Dunselman, G.A.J., Schurgers, L., Evers, J.L.H., and de Goeij, A.F.P.M. (2005). Molecular characterization of soluble factors from human menstrual effluent that induce epithelial to mesenchymal transitions in mesothelial cells. Cell Tissue Res. 322, 299-311.
5. Ejeskar, K., Krona, C., Caren, H., Zaibak, F., Li, L., Martinsson, T., and Ioannou, P. (2005). Introduction of in vitro transcribed ENO1 mRNA into neuroblastoma cells induces cell death. BMC Cancer 5, 161.
6. Executive Yuan. (2006). Taiwan area: death rate of ten leading sites of malignant neoplasms. Taiwan, Department of Health, Executive Yuan, 160-173.
7. Feo, S., Arcuri, D., Piddini, E., Passantino, R., and Giallongo, A. (2000). ENO1 gene product binds to the c-myc promoter and acts as a transcriptional repressor: relationship with Myc promoter-binding protein 1 (MBP-1). FEBS Lett. 473, 47-52.
8. Fujimura, T., Ohta, T., Oyama, K., Miyashita, T., and Miwa, K. (2006). Role of cyclooxygenase-2 in the carcinogenesis of gastrointestinal tract cancers: a review and report of personal experience. World J. Gastroenterol. 12, 1336-1345.
9. Ghosh, A. K., Kanda, T., Steele, R., and Ray, R. B. (2008). Knockdown of MBP-1 in human foreskin fibroblasts induces p53-p21 dependent senescence. PLoS ONE 3, e3384.
10. Ghosh, A. K., Majumder, M., Steele, R., White, R. A., and Ray, R. B. (2001). A novel 16-kilodalton cellular protein physically interacts with and antagonizes the functional activity of c-myc promoter-binding protein 1. Mol. Cell. Biol. 21, 655-662.
11. Ghosh, A. K., Steele, R., and Ray, R. B. (1999). MBP-1 physically associates with histone deacetylase for transcriptional repression. Biochem. Biophys. Res. Commun. 260, 405-409.
12. Ghosh, A. K., Steele, R., and Ray, R. B. (2005a). c-myc promoter-binding protein 1 (MBP-1) regulates prostate cancer cell growth by inhibiting MAPK pathway. J. Biol. Chem. 280, 14325-14330.
13. Ghosh, A. K., Steele, R., and Ray, R. B. (2005b). Carboxyl-terminal repressor domain of MBP-1 is sufficient for regression of prostate tumor growth in nude mice. Cancer Res. 65, 718-721.
14. Ghosh, A. K., Steele, R., and Ray, R. B. (2006a). Knockdown of MBP-1 in human prostate cancer cells delays cell cycle progression. J. Biol. Chem. 281, 23652-23657.
15. Ghosh, A. K., Steele, R., Ryerse, J., and Ray, R. B. (2006b). Tumor-suppressive effects of MBP-1 in non-small cell lung cancer cells. Cancer Res. 66, 11907-11912.
16. Gonzalez, C., Sala, N., and Capella, G. (2002). Genetic susceptibility and gastric cancer risk. Int. J. Cancer 100, 249-260.
17. Hida, T., Yatabe, Y., Achiwa, H., Muramatsu, H., Kozaki, K., Nakamura, S., Ogawa, M., Mitsudomi, T., Sugiura, T., and Takahashi, T. (1998). Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res. 58, 3761-3764.
18. Hsu, K. W., Hsieh, R. H., Lee, Y.H.W., Chao, C. H., Wu, K. J., Tseng, M. J., and Yeh, T. S. (2008). The activated Notch1 receptor cooperates with α-enolase and MBP-1 in modulating c-myc activity. Mol. Cell. Biol. 28, 4829-4842.
19. Ito, S., Honma, T., Ishida, K., Wada, N., Sasaoka, S., Hosoda, M., and Nohno, T. (2007). Differential expression of the human α-enolase gene in oral epithelium and squamous cell carcinoma. Cancer Sci. 98, 499-505.
20. Jiang, X., and Wong, B. (2003). Cyclooxygenase-2 inhibition and gastric cancer. Curr. Pharm. Des. 9, 2281-2288.
21. Katoh, M. (2005). Epithelial-mesenchymal transition in gastric cancer (Review). Int. J. Oncol. 27, 1677-1683.
22. Lee, D., and Moss, S. (2006). COX-2 inhibition and the prevention of gastric cancer. Digestion 74, 184-186.
23. Liao, W. R., Hsieh, R. H., Hsu, K. W., Wu, M. Z., Tseng, M. J., Mai, R. T., Lee, Y.H.W., and Yeh, T. S. (2007). The CBF1-independent Notch1 signal pathway activates human c-myc expression partially via transcription factor YY1. Carcinogenesis 28, 1867-1876.
24. Lim, H. Y., Joo, H. J., Choi, J. H., Yi, J. W., Yang, M. S., Cho, D. Y., Kim, H. S., Nam, D. K., Lee, K. B., and Kim, H. C. (2000). Increased expression of cyclooxygenase-2 protein in human gastric carcinoma. Clin. Cancer Res. 6, 519-525.
25. -/- fibrosarcomas is associated with elevated levels of cyclin kinase inhibitors p21 and p27. Mol. Cell. Biol. 25, 4565-4578.
26. Murata, H., Kawano, S., Tsuji, S., Tsuji, M., Sawaoka, H., Kimura, Y., Shiozaki, H., and Hori, M. (1999). Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma. Am. J. Gastroenterol. 94, 451-455.
27. 2-dependent mechanisms. Carcinogenesis 29, 2227-2235.
28. Ohno, R., Yoshinaga, K., Fujita, T., Hasegawa, K., Iseki, H., Tsunozaki, H., Ichikawa, W., Nihei, Z., and Sugihara, K. (2001). Depth of invasion parallels increased cyclooxygenase-2 levels in patients with gastric carcinoma. Cancer 91, 1876-1881.
29. Perconti, G., Ferro, A., Amato, F., Rubino, P., Randazzo, D., Wolff, T., Feo, S., and Giallongo, A. (2007). The Kelch protein NS1-BP interacts with alpha-enolase/MBP-1 and is involved in c-Myc gene transcriptional control. Biochim. Biophys. Acta 1773, 1774-1785.
30. Ray, R. B., Sheikh, M. S., Fontana, J. F., and Miller, D. M. (1994). Human breast carcinoma cells show correlation in expression of c-myc oncogene and the c-myc binding protein (MBP-1). Int. J. Oncol. 5, 1433-1436.
31. Ray, R. B., Steele, R., Seftor, E., and Hendrix, M. (1995). Human breast carcinoma cells transfected with the gene encoding a c-myc promoter-binding protein (MBP-1) inhibits tumors in nude mice. Cancer Res. 55, 3747-3751.
32. Ristimäki, A., Honkanen, N., Jänkälä, H., Sipponen, P., and Härkönen, M. (1997). Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res. 57, 1276-1280.
33. Roy, M., Pear, W. S., and Aster, J. C. (2007). The multifaceted role of Notch in cancer. Curr. Opin. Genet. Dev. 17, 52-59.
34. Sano, H., Kawahito, Y., Wilder, R. L., Hashiramoto, A., Mukai, S., Asai, K., Kimura, S., Kato, H., Kondo, M., and Hla, T. (1995). Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res. 55, 3785-3789.
35. Shi, H., Xu, J., Hu, N., and Xie, H. (2003). Prognostic significance of expression of cyclooxygenase-2 and vascular endothelial growth factor in human gastric carcinoma. World J. Gastroenterol. 9, 1421-1426.
36. Smith, M., Hold, G., Tahara, E., and El-Omar, E. (2006). Cellular and molecular aspects of gastric cancer. World J. Gastroenterol. 12, 2979-2990.
37. Su, J. L., Shih, J. Y., Yen, M. L., Jeng, Y. M., Chang, C. C., Hsieh, C. Y., Wei, L. H., Yang, P. C., and Kuo, M. L. (2004). Cyclooxygenase-2 induces EP1- and HER-2/Neu-dependent vascular endothelial growth factor-C up-regulation: a novel mechanism of lymphangiogenesis in lung adenocarcinoma. Cancer Res. 64, 554-564.
38. Subramanian, A., and Miller, D. M. (2000). Structural analysis of alpha-enolase: mapping the functional domains involved in down-regulation of the c-myc protooncogene. J. Biol. Chem. 275, 5958-5965.
39. Takashima, M., Kuramitsu, Y., Yokoyama, Y., Iizuka, N., Fujimoto, M., Nishisaka, T., Okita, K., Oka, M., and Nakamura, K. (2005). Overexpression of alpha enolase in hepatitis C virus-related hepatocellular carcinoma: association with tumor progression as determined by proteomic analysis. Proteomics 5, 1686-1692.
40. Terry, M., Gaudet, M., and Gammon, M. (2002). The epidemiology of gastric cancer. Semin. Radiat. Oncol. 12, 111-127.
41. Thiery, J. P., and Sleeman, J. P. (2006). Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell Biol. 7, 131-142.
42. Uefuji, K., Ichikura, T., Mochizuki, H., and Shinomiya, N. (1998). Expression of cyclooxygenase-2 protein in gastric adenocarcinoma. J. Surgical Oncol. 69, 168-172.
43. Ushijima, T., and Sasako, M. (2004). Focus on gastric cancer. Cancer Cell 5, 121-125.
44. Wang, A. M., Ku, H. H., Liang, Y. C., Chen, Y. C., Hwu, Y. M., and Yeh, T. S. (2009). The autonomous Notch signal pathway is activated by baicalin and baicalein but is suppressed by niclosamide in K562 cells. J. Cell. Biochem. 106, 682-692.
45. Wu, C. W., Hsiung, C. A., Lo, S. S., Hsieh, M. C., Chen, J. H., Li, A. F., Lui, W. Y., and Whang-Peng, J. (2006). Nodal dissection for patients with gastric cancer: a randomised controlled trial. Lancet Oncol. 7, 309-315.
46. Yamamoto, H., Itoh, F., Fukushima, H., Hinoda, Y., and Imai, K. (1999). Overexpression of cyclooxygenase-2 protein is less frequent in gastric cancers with microsatellite instability. Int. J. Cancer 84, 400-403.
47. Yeh, T. S., Lin, Y. M., Hsieh, R. H., and Tseng, M. J. (2003). Association of transcription factor YY1 with the high molecular weight Notch complex suppresses the transactivation activity of Notch. J. Biol. Chem. 278, 41963-41969.
48. Zheng, L., Wang, L., Ajani, J., and Xie, K. (2004). Molecular basis of gastric cancer development and progression. Gastric Cancer 7, 61-77.
49. Zimmermann, K. C., Sarbia, M., Weber, A. A., Borchard, F., Gabbert, H. E., and Schrör, K. (1999). Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res. 59, 198-204.